Board Meeting outcome
Awaiting price reaction for this filing.
Sangam Health Care Products Ltd reported audited financial results for FY ended March 2026. Revenue from operations declined to ₹1,123.33 lakhs from ₹1,245.96 lakhs in the previous year, representing approximately a 10% revenue decline. Net profit after tax dropped significantly to ₹5.33 lakhs from ₹44.96 lakhs in FY25, a decline of about 88%. The company posted a net loss of ₹27.89 lakhs in Q4 FY26 compared to a profit of ₹18.76 lakhs in Q4 FY25. Total expenses of ₹1,104.72 lakhs against total income of ₹1,125.44 lakhs indicate very thin operating margins. The statutory auditors M.M. Reddy & Co. issued an unmodified (unqualified) audit opinion, confirming the financial statements present a true and fair view.
The significant decline in revenue and profit, combined with thin operating margins, suggests operational challenges. The auditors have given a clean opinion, but the deteriorating financial performance may concern shareholders.